Leflunomide combined with low-dose prednisone inhibits proinflammatory T cells responses in myasthenia gravis patients
We previously found that leflunomide combined with low-dose prednisone rapidly improved the clinical symptoms of myasthenia gravis (MG), but we had not investigated the mechanism of this phenomenon. This study documents the effect of leflunomide combined with low-dose prednisone on pro-inflammatory...
Main Authors: | Xin Huang, Hao Ran, Yingkai Li, Qian Ma, Changyi Ou, Li Qiu, Huiyu Feng, Weibin Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2022.961628/full |
Similar Items
-
Corrigendum: Leflunomide combined with low-dose prednisone inhibits proinflammatory T cells responses in myasthenia gravis patients
by: Xin Huang, et al.
Published: (2023-03-01) -
Efficacy of leflunomide combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy
by: Yaling Guo, et al.
Published: (2020-01-01) -
Huangkui Capsule in Combination with Leflunomide Improves Immunoglobulin A Nephropathy by Inhibiting the TGF-β1/Smad3 Signaling Pathway
by: Shuwen Pei, et al.
Published: (2021-12-01) -
Clinical Characteristics of Juvenile Myasthenia Gravis in Southern China
by: Xin Huang, et al.
Published: (2018-02-01) -
Elevated profiles of peripheral Th22, Th17, Th2 cells, and decreased percentage of Th1 cells in breast cancer patients
by: Zhiguo Peng, et al.
Published: (2023-11-01)